Global Search | Novartis United States of America

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 893 results

Story / May 21, 2025

How We’re Reimagining Cancer Care for the Next Generation Patient

Discovery
Story / May 13, 2025

Autoimmune Diseases Disproportionately Impact Women — Here’s Why That Matters

Education and Awareness

Novartis is raising awareness about the disproportionate impact and often invisible burden of autoimmune diseases on women.
Novartis commitment to patients and caregivers
Patient assistance
Employee benefits
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Story / Mar 12, 2025

Novartis joins Susan G. Komen in first-of-its-kind breast cancer policy coalition

Education and Awareness
Story / Feb 18, 2025

Advancing Prostate Cancer Care: A Bold New Partnership to Help Patients

Education and Awareness
Media Release / Jul 07, 2015

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril/valsartan)

First in the world approval brings hope of longer life and fewer HF hospitalizations by reducing the devastating impact of heart failure with reduced ejection fraction for millions of patients in the…
Novartis in Society Integrated Report

‹ Previous page
1
…
17
18
19
20
21
22
23
…
90
› Next page